81 related articles for article (PubMed ID: 20116920)
21. [Expression of RAS protein in glioma and its effect on the growth of human glioma cells].
Cao L; Wang YY; Wang XR; Wang XF; Sun G; Luo H; Liu N; You YP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):159-62. PubMed ID: 22487824
[TBL] [Abstract][Full Text] [Related]
22. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.
Sun M; Paciga JE; Feldman RI; Yuan Z; Coppola D; Lu YY; Shelley SA; Nicosia SV; Cheng JQ
Cancer Res; 2001 Aug; 61(16):5985-91. PubMed ID: 11507039
[TBL] [Abstract][Full Text] [Related]
23. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
[TBL] [Abstract][Full Text] [Related]
24. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
[TBL] [Abstract][Full Text] [Related]
25. Increased levels of p21WAF1/Cip1 in human brain tumors.
Jung JM; Bruner JM; Ruan S; Langford LA; Kyritsis AP; Kobayashi T; Levin VA; Zhang W
Oncogene; 1995 Nov; 11(10):2021-8. PubMed ID: 7478521
[TBL] [Abstract][Full Text] [Related]
26. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
[TBL] [Abstract][Full Text] [Related]
27. GDF-15 contributes to proliferation and immune escape of malignant gliomas.
Roth P; Junker M; Tritschler I; Mittelbronn M; Dombrowski Y; Breit SN; Tabatabai G; Wick W; Weller M; Wischhusen J
Clin Cancer Res; 2010 Aug; 16(15):3851-9. PubMed ID: 20534737
[TBL] [Abstract][Full Text] [Related]
28. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
Das G; Shiras A; Shanmuganandam K; Shastry P
Mol Carcinog; 2011 Jun; 50(6):412-23. PubMed ID: 21557327
[TBL] [Abstract][Full Text] [Related]
29. Isolation of a natural inhibitor of human malignant glial cell invasion: inter alpha-trypsin inhibitor heavy chain 2.
Werbowetski-Ogilvie TE; Agar NY; Waldkircher de Oliveira RM; Faury D; Antel JP; Jabado N; Del Maestro RF
Cancer Res; 2006 Feb; 66(3):1464-72. PubMed ID: 16452202
[TBL] [Abstract][Full Text] [Related]
30. Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome.
Zolota V; Tsamandas AC; Aroukatos P; Panagiotopoulos V; Maraziotis T; Poulos C; Scopa CD
Neuropathology; 2008 Feb; 28(1):35-42. PubMed ID: 18181833
[TBL] [Abstract][Full Text] [Related]
31. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
Kong L; Li Q; Wang L; Liu Z; Sun T
Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371
[TBL] [Abstract][Full Text] [Related]
32. Expression of cyclinD1 and Ki-67 proteins in gliomas and its clinical significance.
Qu DW; Xu HS; Han XJ; Wang YL; Ouyang CJ
Eur Rev Med Pharmacol Sci; 2014; 18(4):516-9. PubMed ID: 24610618
[TBL] [Abstract][Full Text] [Related]
33. The effects of antisense AKT2 RNA on the inhibition of malignant glioma cell growth in vitro and in vivo.
Pu P; Kang C; Li J; Jiang H; Cheng J
J Neurooncol; 2006 Jan; 76(1):1-11. PubMed ID: 16402276
[TBL] [Abstract][Full Text] [Related]
34. BRAF overexpression induces rampant glioma proliferation independent of phospho-EGFR expression.
Li M; Wei M; Jiang Z; Wei H; Lu W; Dou W; Lu S
Adv Clin Exp Med; 2014; 23(6):893-9. PubMed ID: 25618114
[TBL] [Abstract][Full Text] [Related]
35. TROP2 expression and its correlation with tumor proliferation and angiogenesis in human gliomas.
Ning S; Liang N; Liu B; Chen X; Pang Q; Xin T
Neurol Sci; 2013 Oct; 34(10):1745-50. PubMed ID: 23397225
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of DcR3 and its significance on tumor cell differentiation and proliferation in glioma.
Huang S; Chen G; Dang Y; Chen LH
ScientificWorldJournal; 2014; 2014():605236. PubMed ID: 24741354
[TBL] [Abstract][Full Text] [Related]
37. Clinical Evaluation of P21 Activated Kinase 1 (PAK1) Activation in Gliomas and Its Effect on Cell Proliferation.
Venu A; Archana B; Kanumuri R; Vuttaradhi VK; D'Cruze L; Murugan S; Ganesh K; Prathiba D; Dymova MA; Rayala SK; Venkatraman G
Cancer Invest; 2021 Jan; 39(1):98-113. PubMed ID: 33251876
[TBL] [Abstract][Full Text] [Related]
38. Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index.
Coons SW; Johnson PC
J Neuropathol Exp Neurol; 1993 Nov; 52(6):609-18. PubMed ID: 8229080
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of phosphatidylinositol 3-kinase in human lung cancer.
Lin X; Böhle AS; Dohrmann P; Leuschner I; Schulz A; Kremer B; Fändrich F
Langenbecks Arch Surg; 2001 Jul; 386(4):293-301. PubMed ID: 11466572
[TBL] [Abstract][Full Text] [Related]
40. Ki-67 labelling index in human brain tumours.
Niemiec J
Folia Histochem Cytobiol; 2001; 39(3):259-62. PubMed ID: 11534782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
